Idelalisib

Idelalisib
  • CAS No.:870281-82-6
  • Grade:> 95%
  • Formula:C22H18FN7O
  • M.W.:415.432
  • Solvent:pH-dependent solubility ranging from <0.1 mg/mL at pH 5-7 to over 1 mg/mL at pH 2 under ambient conditions

Overview

Idelalisib is a kinase inhibitor. In combination with rituximab, it was used for the treatment of relapsed or refractory chronic lymphocytic leukemia (CLL).

Application

Products > Drug Discovery > Impurities > Anti-Neoplastic > Idelalisib and Impurities | Products > Drug Discovery > Inhibitor

Product Information

  • Catalog No.: B0084-307712
  • CAS No.: 870281-82-6
  • Molecular Formula: C22H18FN7O
  • Molecular Weight: 415.432
  • Purity: > 95%
  • Solubility: pH-dependent solubility ranging from <0.1 mg/mL at pH 5-7 to over 1 mg/mL at pH 2 under ambient conditions

Source

Original product source


Welcome!

Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.

  • NO. 18 ,Wujiang Road, Wulidian Street, Jiangbei District, Chongqing
  • +86-23-6139-8061 +86-13650506873
  • danny@chemdad.com sales@chemdad.com
  • www.chemdad.com
  • WhatsApp +86-13650506873

Name

phone

company

email

message

Payment methods
Google translate: 日本语日本语 한국어한국어 FrançaisFrançais DeutschDeutsch EspañaEspaña TürkiyeTürkiye